[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX358390B - Interleucina 6 y receptor de interleucina 6, humanizados. - Google Patents

Interleucina 6 y receptor de interleucina 6, humanizados.

Info

Publication number
MX358390B
MX358390B MX2014004900A MX2014004900A MX358390B MX 358390 B MX358390 B MX 358390B MX 2014004900 A MX2014004900 A MX 2014004900A MX 2014004900 A MX2014004900 A MX 2014004900A MX 358390 B MX358390 B MX 358390B
Authority
MX
Mexico
Prior art keywords
mice
mouse
encoding sequence
replacement
human
Prior art date
Application number
MX2014004900A
Other languages
English (en)
Other versions
MX2014004900A (es
Inventor
J Murphy Andrew
Wang Li-Hsien
T Dore Anthony Jr
Stevens Sean
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2014004900A publication Critical patent/MX2014004900A/es
Publication of MX358390B publication Critical patent/MX358390B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a ratones que comprenden una sustitución de los genes para IL-6 y/o receptor de IL-6 de ratón endógenos y se describen métodos para producir y utilizar a estos ratones. Se proporcionan ratones que comprenden una sustitución en el locus IL-6Ra endógeno de la secuencia que codifica para el ectodominio de ratón con una secuencia que codifica para el ectodominio humano. También se proporcionan ratones que comprenden un gen para IL-6 humana bajo el control de los elementos reguladores de IL-6 de ratón, que incluye a ratones que tienen una sustitución de la secuencia que codifica para IL-6 de ratón con una secuencia que codifica para IL-6 de humano en un locus IL-6 de ratón endógeno.
MX2014004900A 2011-10-28 2012-10-29 Interleucina 6 y receptor de interleucina 6, humanizados. MX358390B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US201161556579P 2011-11-07 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Publications (2)

Publication Number Publication Date
MX2014004900A MX2014004900A (es) 2014-08-26
MX358390B true MX358390B (es) 2018-08-17

Family

ID=47295138

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004900A MX358390B (es) 2011-10-28 2012-10-29 Interleucina 6 y receptor de interleucina 6, humanizados.

Country Status (28)

Country Link
US (9) US8878001B2 (es)
EP (2) EP2818478B1 (es)
JP (2) JP6120451B2 (es)
KR (2) KR102234632B1 (es)
CN (2) CN108866101A (es)
AU (1) AU2015207889B2 (es)
BR (1) BR112014008529A2 (es)
CA (1) CA2853731C (es)
CY (2) CY1116614T1 (es)
DK (2) DK2663575T3 (es)
ES (2) ES2525368T3 (es)
HK (2) HK1190408A1 (es)
HR (2) HRP20141192T1 (es)
HU (1) HUE033400T2 (es)
IL (4) IL231896B (es)
IN (1) IN2014CN03920A (es)
LT (1) LT2818478T (es)
MX (1) MX358390B (es)
MY (2) MY172726A (es)
PL (2) PL2663575T3 (es)
PT (2) PT2663575E (es)
RS (2) RS53683B1 (es)
RU (2) RU2751240C2 (es)
SG (3) SG11201400945UA (es)
SI (2) SI2818478T1 (es)
SM (1) SMT201400187B (es)
WO (1) WO2013063556A1 (es)
ZA (1) ZA201402635B (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3417701T3 (da) 2009-10-06 2022-03-14 Regeneron Pharma Genmodificerede mus og indpodning
DK3375284T3 (da) 2011-02-15 2023-06-12 Univ Yale Humaniserede M-CSF-mus og anvendelser deraf
MY172726A (en) 2011-10-28 2019-12-11 Regeneron Pharma Humanized il-6 and il-6 receptor
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
DK2892330T3 (da) 2012-09-07 2023-01-30 Univ Yale Genetisk modificeret mus og fremgangsmåder til anvendelse deraf
WO2014042251A1 (ja) * 2012-09-13 2014-03-20 中外製薬株式会社 遺伝子ノックイン非ヒト動物
DK3939423T3 (da) * 2012-11-05 2024-05-06 Regeneron Pharma Genetisk modificerede ikke-humane dyr og fremgangsmåder til anvendelse deraf
KR102579405B1 (ko) 2013-02-20 2023-09-18 리제너론 파아마슈티컬스, 인크. 사람화된 ｔ-세포 보조-수용체를 발현하는 마우스
JP6444321B2 (ja) 2013-02-22 2018-12-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ヒト化主要組織適合性遺伝子複合体を発現するマウス
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
HRP20231121T1 (hr) * 2013-09-23 2023-12-22 Regeneron Pharmaceuticals, Inc. Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale
ES2715949T3 (es) * 2013-10-15 2019-06-07 Regeneron Pharma Animales con IL-15 humanizada
KR102173297B1 (ko) 2013-11-19 2020-11-03 리제너론 파마슈티칼스 인코포레이티드 인간화된 증식-유도 리간드 유전자를 가지고 있는 비-인간 동물
BR112016011003A2 (pt) * 2013-11-19 2017-12-05 Regeneron Pharma animal roedor geneticamente modificado, célula tronco embrionária de camundongo, embrião de camundongo, e, métodos para fabricar um animal roedor e para enxertar células humanas em um camundongo
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
AU2015315834B2 (en) 2014-01-31 2019-12-12 Boehringer Ingelheim International Gmbh Novel anti-BAFF antibodies
RU2019128394A (ru) 2014-04-08 2019-10-07 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы
MX2016014504A (es) 2014-05-05 2017-05-23 Regeneron Pharma Animales c5 y c3 humanizados.
NO2785538T3 (es) 2014-05-07 2018-08-04
US10463028B2 (en) 2014-05-19 2019-11-05 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human EPO
JP6212659B2 (ja) * 2014-05-30 2017-10-11 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ヒト化ジペプチジルペプチダーゼｉｖ（ｄｐｐ４）動物
EP3157956B1 (en) 2014-06-19 2020-02-05 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized programmed cell death 1 gene
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
BR112017010793A2 (pt) 2014-11-24 2017-12-26 Regeneron Pharma animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo.
CA2967834C (en) * 2014-12-05 2024-01-16 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 47 gene
AU2015360667B2 (en) 2014-12-09 2021-09-23 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 274 gene
EP3537265B1 (en) 2015-02-20 2021-09-29 Ultrahaptics Ip Ltd Perceptions in a haptic system
MX2017010252A (es) 2015-02-20 2018-03-07 Ultrahaptics Ip Ltd Mejoras de algoritmos en un sistema haptico.
PL3280257T3 (pl) 2015-04-06 2023-10-23 Regeneron Pharmaceuticals, Inc. Odpowiedzi odpornościowe za pośrednictwem humanizowanych komórek t u zwierząt innych niż człowiek
IL302370A (en) 2015-04-13 2023-06-01 Regeneron Pharma Mice genetically engineered to express signal-regulating protein alpha and interleukin 15 and methods of using them
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
ES2872799T3 (es) 2015-11-20 2021-11-02 Regeneron Pharma Animales no humanos que tienen un gen 3 de activación linfocitaria humanizado
DK3782639T3 (da) 2015-12-08 2022-08-29 Regeneron Pharma Sammensætninger og fremgangsmåder til internalisering af enzymer
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
KR102487839B1 (ko) 2016-02-04 2023-01-12 리제너론 파마슈티칼스 인코포레이티드 조작된 angptl8 유전자를 갖는 비인간 동물
AU2017228293B2 (en) 2016-02-29 2023-05-25 Regeneron Pharmaceuticals, Inc. Rodents having a humanized Tmprss gene
LT3462853T (lt) 2016-06-03 2023-03-27 Regeneron Pharmaceuticals, Inc. Graužikai, vykdantys egzogeninės terminalinės deoksinukleotidiltransferazės raišką
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (zh) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
WO2018177441A1 (en) * 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
CN111163633B (zh) 2017-09-29 2022-09-09 瑞泽恩制药公司 包含人源化ttr基因座的非人类动物及其使用方法
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
CN111655031B (zh) 2017-11-30 2022-11-18 瑞泽恩制药公司 包含人源化trkb基因座的非人动物
EP3729418A1 (en) 2017-12-22 2020-10-28 Ultrahaptics Ip Ltd Minimizing unwanted responses in haptic systems
US11360546B2 (en) 2017-12-22 2022-06-14 Ultrahaptics Ip Ltd Tracking in haptic systems
EP3772926A1 (en) 2018-03-26 2021-02-17 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
AU2019264014A1 (en) 2018-05-02 2020-12-03 Ultrahaptics Ip Ltd Blocking plate structure for improved acoustic transmission efficiency
EP3823443B1 (en) * 2018-07-16 2024-05-22 Regeneron Pharmaceuticals, Inc. Rodent models of ditra disease and uses thereof
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
CN111837036B (zh) * 2018-12-17 2024-06-18 百奥赛图江苏基因生物技术有限公司 具有人或嵌合基因的基因修饰的非人动物
EP3906462A2 (en) 2019-01-04 2021-11-10 Ultrahaptics IP Ltd Mid-air haptic textures
CN111218425B (zh) * 2019-01-17 2022-02-08 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
WO2020206139A1 (en) 2019-04-04 2020-10-08 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized coagulation factor 12 locus
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
EP3978607A4 (en) * 2019-05-27 2023-01-25 Transgenic Inc. HUMANIZED EXON MOUSE
CA3137761A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
CA3137764A1 (en) 2019-06-07 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
WO2021074604A1 (en) 2019-10-13 2021-04-22 Ultraleap Limited Dynamic capping with virtual microphones
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
WO2021090028A1 (en) 2019-11-08 2021-05-14 Ultraleap Limited Tracking techniques in haptics systems
CN111304246B (zh) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 一种人源化细胞因子动物模型、制备方法及应用
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
US20210227812A1 (en) * 2020-01-28 2021-07-29 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
US20230172170A1 (en) 2020-04-21 2023-06-08 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cxcl13 gene
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
US11886639B2 (en) 2020-09-17 2024-01-30 Ultraleap Limited Ultrahapticons
US20240224964A9 (en) 2022-09-29 2024-07-11 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012025A1 (en) * 1994-10-14 1996-04-25 Basf Aktiengesellschaft TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE
HU227708B1 (en) 1994-10-21 2011-12-28 Chugai Pharmaceutical Co Ltd Use of anti-interleukin-6-receptor antibodies mr-16 and pm-1 and derivatives thereof for producing pharmaceutical preparation for treating diseases caused by il-6 production
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (zh) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 用能产生人IgGl重链－κ轻链小鼠作为制备人源化单克隆抗体和应用
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
SI2374818T1 (sl) 2006-06-02 2013-03-29 Regeneron Pharmaceuticals, Inc. Visokoafinitetna protitelesa za humani IL-6 receptor
SG174053A1 (en) * 2006-09-01 2011-09-29 Therapeutic Human Polyclonals Inc Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
FR2942218A1 (fr) 2009-02-13 2010-08-20 Eurocave Sa Appareil de service au verre d'un liquide, notamment de vin
DK3417701T3 (da) 2009-10-06 2022-03-14 Regeneron Pharma Genmodificerede mus og indpodning
WO2011084664A1 (en) * 2009-12-21 2011-07-14 Regeneron Pharmaceuticals, Inc. HUMANIZED FCγ R MICE
DK3375284T3 (da) 2011-02-15 2023-06-12 Univ Yale Humaniserede M-CSF-mus og anvendelser deraf
SG10201510341XA (en) * 2011-09-30 2016-01-28 Chugai Pharmaceutical Co Ltd Antigen-binding molecule inducing immune response to target antigen
ES2914374T3 (es) 2011-10-28 2022-06-10 Regeneron Pharma Ratones modificados genéticamente que expresan moléculas quiméricas del complejo de histocompatibilidad mayor (MHC) de clase II
RS56656B1 (sr) 2011-10-28 2018-03-30 Regeneron Pharma Miševi sa genetski modifikovanim glavnim kompleksom gena tkivne podudarnosti
MY172726A (en) 2011-10-28 2019-12-11 Regeneron Pharma Humanized il-6 and il-6 receptor

Also Published As

Publication number Publication date
RS53683B1 (en) 2015-04-30
RU2017129763A (ru) 2019-02-05
IN2014CN03920A (es) 2015-09-04
DK2818478T3 (en) 2017-05-22
AU2015207889A1 (en) 2015-08-20
WO2013063556A4 (en) 2013-06-20
IL231896B (en) 2018-02-28
US10433528B2 (en) 2019-10-08
WO2013063556A8 (en) 2014-04-17
HRP20170656T1 (hr) 2017-06-30
US20200008407A1 (en) 2020-01-09
KR102084927B1 (ko) 2020-03-06
US20220053742A1 (en) 2022-02-24
US11102962B2 (en) 2021-08-31
KR20140091024A (ko) 2014-07-18
PT2663575E (pt) 2014-12-05
SI2663575T1 (sl) 2015-01-30
CA2853731A1 (en) 2013-05-02
IL231896A0 (en) 2014-05-28
EP2663575A1 (en) 2013-11-20
IL264508B (en) 2019-12-31
KR102234632B1 (ko) 2021-04-02
ES2624605T3 (es) 2017-07-17
US20160278352A1 (en) 2016-09-29
ES2525368T3 (es) 2014-12-23
IL243666A0 (en) 2016-03-31
AU2015207889B2 (en) 2017-02-23
US20150013023A1 (en) 2015-01-08
DK2663575T3 (en) 2014-12-15
HK1190408A1 (en) 2014-07-04
CY1116614T1 (el) 2017-03-15
LT2818478T (lt) 2017-06-12
US10004211B2 (en) 2018-06-26
CY1118952T1 (el) 2018-01-10
JP2014532416A (ja) 2014-12-08
PT2818478T (pt) 2017-05-12
US8878001B2 (en) 2014-11-04
KR20200024949A (ko) 2020-03-09
US9392777B2 (en) 2016-07-19
RU2014121324A (ru) 2015-12-10
US20150272092A1 (en) 2015-10-01
SG11201400945UA (en) 2014-04-28
WO2013063556A1 (en) 2013-05-02
US20180271071A1 (en) 2018-09-27
SG10202100485XA (en) 2021-02-25
SG10201600965YA (en) 2016-03-30
CN104039821A (zh) 2014-09-10
US9622460B2 (en) 2017-04-18
RU2017129763A3 (es) 2020-12-18
US9078418B2 (en) 2015-07-14
IL264508A (en) 2019-02-28
CA2853731C (en) 2021-05-18
SI2818478T1 (sl) 2017-07-31
HK1205135A1 (en) 2015-12-11
EP2818478A1 (en) 2014-12-31
US20130117873A1 (en) 2013-05-09
HUE033400T2 (en) 2017-12-28
MX2014004900A (es) 2014-08-26
NZ623145A (en) 2015-09-25
IL243665A0 (en) 2016-03-31
EP2818478B1 (en) 2017-02-01
IL243666B (en) 2019-02-28
IL243665B (en) 2018-02-28
US20150013022A1 (en) 2015-01-08
SMT201400187B (it) 2015-01-15
MY186903A (en) 2021-08-26
NZ709432A (en) 2015-12-24
JP6120451B2 (ja) 2017-04-26
MY172726A (en) 2019-12-11
BR112014008529A2 (pt) 2017-04-18
RU2751240C2 (ru) 2021-07-12
JP2017035115A (ja) 2017-02-16
RS55949B1 (sr) 2017-09-29
US9125386B2 (en) 2015-09-08
US20170055506A1 (en) 2017-03-02
EP2663575B1 (en) 2014-10-01
HRP20141192T1 (hr) 2015-02-13
ZA201402635B (en) 2015-09-30
PL2663575T3 (pl) 2015-03-31
RU2634417C2 (ru) 2017-10-26
PL2818478T3 (pl) 2017-09-29
CN108866101A (zh) 2018-11-23

Similar Documents

Publication Publication Date Title
MX358390B (es) Interleucina 6 y receptor de interleucina 6, humanizados.
MX2016003636A (es) Animales no humanos que tienen un gen de proteina reguladora de señal humanizado.
PH12016502058A1 (en) Humanized il-4 and il-4r alpha animals
MX2022009625A (es) Receptores de antigenos quimericos condicionalmente activos para celulas t modificadas.
MX2024004386A (es) Dianas terapeuticas para la correccion del gen de la distrofina humana por edicion genica y metodos de uso.
MX2014015679A (es) Roedores con il-7 humanizada.
NZ601679A (en) Common light chain mouse
MX2016014504A (es) Animales c5 y c3 humanizados.
EP3180075A4 (en) Integrated electromyographic clinician programmer for use with an implantable neurostimulator
EP3359689A4 (en) DIAGNOSTIC USE OF GENETIC SIGNATURE FOR EVALUATING PROSTATE CANCER TREATMENT STRATEGIES
PH12016502170A1 (en) Humanized dipeptidyl peptidase iv (dpp4) animals
MY183189A (en) Non-human animals having a humanized a proliferation-inducing ligand gene
SG10201908800YA (en) Non-human animals having humanized fc-gamma receptors
MY183188A (en) Non-human animals having a humanized b-cell activating factor gene
EP3565891A4 (en) PROCESSES FOR MODIFYING THE GENE EXPRESSION BY DISTURBING MULTIMERS OF THE TRANSCRIPTION FACTOR WHICH STRUCTURE THE REGULATORY LOOPS
IL279281A (en) Optimizing BAG3 gene therapy
EP3271718A4 (en) Phenotypic personalized medicine: adaptive optimization of patient-specific combination therapy
IL280531A (en) Methods for gene therapy to control organ function
MX2016003248A (es) Metodos de uso de anticuerpos anti-lgr5.
EP3114241A4 (en) Fibroblast growth factor-2 (fgf2) and syndecan-1 (sdc1) as biomarkers for poor outcome hodgkin lymphoma patients
UA61938U (ru) СПОСОБ ЛЕЧЕНИЯ больных с болевымИ нейрокомпрессионныМИ спондилогенныМИ СИНДРОМАМИ

Legal Events

Date Code Title Description
FG Grant or registration